Clinical trial with ivermectine for the treatment of Mansonella ozzardi infections
Phase 4
Completed
- Conditions
- Mansoneliasis caused by Mansonella ozzardiPublic Health - Epidemiology
- Registration Number
- ACTRN12609000005257
- Lead Sponsor
- niversity of Sao Paulo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
1-)Mansonella ozzardi parasitaemia present on hemoscopy
2-)Older than 4 years and younger than 61 years
3-)Not pregnant or breast-feeding
4-) Volunteer
Exclusion Criteria
1-)Pregnant or breast-feeding women
2-)Less than 5 years old and older than 60 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Microfilaremia clearance 30 and 180 days post ivermectin treatment[3, 30, 60 and 180 days post ivermectine treatment]
- Secondary Outcome Measures
Name Time Method Side-effects caused by ivermectin[3 days post ivermectine treatment]